Statistics for AC Immune SA (id:6740 ACIU)

Valuation metrics

Market cap

310.19M

Enterprise value

185.31M

Trailing P/E (ttm)

-5.06

Forward P/E

-12.54

PEG ratio

-12.54

Price/Sales (ttm)

7.57

Price/Book (mrq)

2.40

Enterprise Value/Revenue

4.00

Enterprise Value/EBITDA

-4.58

Overview

Shares outstanding

98.94M

Float

40.73M

Shares short

984.46K

% Held by insiders

0.22%

% Held by institutions

0.29%

Average volume (10 days)

192.52K

Average volume (90 days)

Price summary

52-Week low

2.25

52-Week high

5.14

52-Week change

5.56%

Beta

1.28

50-Day moving average

3.28

200-Day moving average

3.34

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-97.29%

Operating margin

28.52%

Operational effectiveness

Return on assets

-12.04%

Return on equity

-31.16%

Income statement

Revenue (ttm)

0.42

Revenue per share (ttm)

0.42

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-40,484,134.00

Net income to common (ttm)

-45,131,692.00

Diluted EPS (ttm)

-0.45

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

178.76M

Total cash per share (mrq)

1.58

Total debt (mrq)

3.49M

Total Debt/Equity (mrq)

2.37

Current ratio (mrq)

185.80%

Book value per share (mrq)

1.30

Cash flow

Cash flow statement

49.50M

Levered free cash flow (LFCF)

56.04M